Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
about
May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?Roles for miRNAs in endocrine resistance in breast cancerTargeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implicationsMiR-200, a new star miRNA in human cancerEpithelial-Mesenchymal Plasticity: A Central Regulator of Cancer ProgressionMinireview: Deciphering the Cellular Functions of PELP1The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers.A review of molecular events of cadmium-induced carcinogenesisFor robust big data analyses: a collection of 150 important pro-metastatic genesHDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.Cytoplasmic Localization of Proline, Glutamic Acid, Leucine-rich Protein 1 (PELP1) Induces Breast Epithelial Cell Migration through Up-regulation of Inhibitor of κB Kinase ϵ and Inflammatory Cross-talk with Macrophages.MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer.MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.β-Bisabolene, a Sesquiterpene from the Essential Oil Extract of Opoponax (Commiphora guidottii), Exhibits Cytotoxicity in Breast Cancer Cell Lines.MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cellsSnail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivitymiR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity.PELP1: Structure, biological function and clinical significance.Noncoding RNAs in breast cancer.Epigenetic modification of miR-141 regulates SKA2 by an endogenous 'sponge' HOTAIR in glioma.Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth.Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.Honokiol suppresses renal cancer cells' metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling.Genome-wide miRNA response to anacardic acid in breast cancer cells.Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients.HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL.MiRNA-200a induce cell apoptosis in renal cell carcinoma by directly targeting SIRT1.MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer.miR-506 attenuates methylation of lncRNA to inhibit migration and invasion of breast cancer cell lines via targeting SP1 and SP3
P2860
Q26780339-CA92801A-6D1C-41D1-8F4D-66A8B95FDEBCQ26783076-7962E465-17F7-42B8-ABD2-D725CF0C373AQ26853394-EB5A8781-E40D-4F16-A661-77D47A4D0B2AQ27004023-C73EAA40-E4B4-434D-8CA7-D94D9878B7ECQ28081012-E9CE661A-BC57-4E38-9FB5-6F8FAB7F2FEFQ28264812-3170DCC2-2E1B-46B5-A311-4DA12573EA58Q28389376-5C45E0E0-F7B9-454D-9396-5E83DC6A73ADQ28395274-AFB2FD27-BF72-4C55-856D-BFB810BD9E4BQ31155755-D4F2D233-21E8-4D38-84ED-FC38C0BCA7C0Q33733042-32CF67EC-C37B-4C2B-8FEC-4FD266656BE2Q34545700-A71B02DC-B2DB-4BFD-BE71-258807983C89Q34774540-7B06B028-9D54-4E63-BBE3-FBA4E68ECF55Q35094742-7A99F6FA-AC7B-41FF-8B94-CFADD7ECCC3AQ35138841-9D106BFF-88D7-44A0-B190-334BB9394167Q35748163-6D334D70-2B7B-492B-840A-B27EBAA3732CQ35824823-B270010D-FC22-4F5B-8C8C-5139714F5664Q35868431-A1005C2E-86B3-4DB4-94F6-488EB95ABF0FQ35955244-61D57DB8-D14E-4084-A78D-1BCF6CB2D2ABQ35961794-B9DA3FAA-A341-44FB-AE53-D25CAA6F4998Q36191985-78FC5ED6-C536-4A39-8CB3-96720A398004Q36485955-A716D0A7-46BB-48AD-B53E-0A7DB6E7003CQ36544974-7973AEDB-C32A-41D4-A1FA-5B4D4F7D2860Q36818434-39556C7D-1223-4371-A2A4-D9BA1FF47FC7Q36935047-D254CA1A-59CB-4E27-9C43-28D2AE766010Q37327566-B1AF40AF-F61A-46F6-92F6-3CD3A06E0335Q37693436-63DDC421-5A05-4218-8FCD-749EC0C20D22Q37745219-D7C0A54D-28C9-483E-B08F-9615A63EB0E7Q39630055-7F48E87C-B9C6-4847-B296-DFDC22E83422Q40264482-33EB3226-AFE7-4EF2-8477-3360339B73C1Q41491494-7B518EC0-354C-49A0-87BF-FAC3EDF47B90Q47130059-19E11759-3EE9-4258-925E-7157B1FC2617Q47385628-C2426966-EF2B-4C25-B92B-075CDD8EADB6Q50884714-C5A5226A-D0F5-4982-87B8-C25B02C4DFB6Q55017551-215DA0C2-970A-4864-B375-7E61EB93B2E3Q58553627-FA25CD19-A504-4AE1-922E-0A48F77758B2
P2860
Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Significance of PELP1/HDAC2/mi ...... nd metastasis of breast cancer
@ast
Significance of PELP1/HDAC2/mi ...... nd metastasis of breast cancer
@en
Significance of PELP1/HDAC2/mi ...... nd metastasis of breast cancer
@nl
type
label
Significance of PELP1/HDAC2/mi ...... nd metastasis of breast cancer
@ast
Significance of PELP1/HDAC2/mi ...... nd metastasis of breast cancer
@en
Significance of PELP1/HDAC2/mi ...... nd metastasis of breast cancer
@nl
prefLabel
Significance of PELP1/HDAC2/mi ...... nd metastasis of breast cancer
@ast
Significance of PELP1/HDAC2/mi ...... nd metastasis of breast cancer
@en
Significance of PELP1/HDAC2/mi ...... nd metastasis of breast cancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
Significance of PELP1/HDAC2/mi ...... nd metastasis of breast cancer
@en
P2093
A Bandyopadhyay
R K Vadlamudi
R R Tekmal
V K Gonugunta
P2860
P2888
P304
P3181
P356
10.1038/ONC.2013.332
P407
P577
2013-08-26T00:00:00Z
P5875
P6179
1000532861